Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Cha, MY | - |
dc.contributor.author | Choi, BC | - |
dc.contributor.author | Kang, KH | - |
dc.contributor.author | Pae, AN | - |
dc.contributor.author | Choi, KI | - |
dc.contributor.author | Cho, YS | - |
dc.contributor.author | Koh, HY | - |
dc.contributor.author | Lee, HY | - |
dc.contributor.author | Jung, D | - |
dc.contributor.author | Kong, JY | - |
dc.date.accessioned | 2024-01-21T10:37:42Z | - |
dc.date.available | 2024-01-21T10:37:42Z | - |
dc.date.created | 2021-09-01 | - |
dc.date.issued | 2002-05-20 | - |
dc.identifier.issn | 0960-894X | - |
dc.identifier.uri | https://pubs.kist.re.kr/handle/201004/139519 | - |
dc.description.abstract | A piperazinylbutylisoxazole libary was designed, synthesized and screened for the binding affinities to dopamine D-2, D-3, and D-4 receptors. Several ligands were identified to possess high binding affinity and selectivity for the D-3 and D-4 receptors over the D-2 receptor. Compounds 6s and 6t showed K-i values of 2.6 nM and 3.9 nM for the D-3 receptor with 46- and 50-fold selectivity over the D-3 receptor, respectively. (C) 2002 Elsevier Science Ltd. All rights reserved. | - |
dc.language | English | - |
dc.publisher | PERGAMON-ELSEVIER SCIENCE LTD | - |
dc.subject | MOLECULAR-CLONING | - |
dc.subject | HIGH-AFFINITY | - |
dc.subject | D-3 RECEPTOR | - |
dc.subject | ANTAGONIST | - |
dc.subject | GENE | - |
dc.subject | HALOPERIDOL | - |
dc.subject | EFFICACY | - |
dc.subject | AGONIST | - |
dc.subject | CYCLASE | - |
dc.subject | POTENT | - |
dc.title | Design and synthesis of a piperazinylalkylisoxazole library for subtype selective dopamine receptor ligands | - |
dc.type | Article | - |
dc.identifier.doi | 10.1016/S0960-894X(02)00179-8 | - |
dc.description.journalClass | 1 | - |
dc.identifier.bibliographicCitation | BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, v.12, no.10, pp.1327 - 1330 | - |
dc.citation.title | BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | - |
dc.citation.volume | 12 | - |
dc.citation.number | 10 | - |
dc.citation.startPage | 1327 | - |
dc.citation.endPage | 1330 | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.identifier.wosid | 000175648800001 | - |
dc.identifier.scopusid | 2-s2.0-18344391187 | - |
dc.relation.journalWebOfScienceCategory | Chemistry, Medicinal | - |
dc.relation.journalWebOfScienceCategory | Chemistry, Organic | - |
dc.relation.journalResearchArea | Pharmacology & Pharmacy | - |
dc.relation.journalResearchArea | Chemistry | - |
dc.type.docType | Article | - |
dc.subject.keywordPlus | MOLECULAR-CLONING | - |
dc.subject.keywordPlus | HIGH-AFFINITY | - |
dc.subject.keywordPlus | D-3 RECEPTOR | - |
dc.subject.keywordPlus | ANTAGONIST | - |
dc.subject.keywordPlus | GENE | - |
dc.subject.keywordPlus | HALOPERIDOL | - |
dc.subject.keywordPlus | EFFICACY | - |
dc.subject.keywordPlus | AGONIST | - |
dc.subject.keywordPlus | CYCLASE | - |
dc.subject.keywordPlus | POTENT | - |
dc.subject.keywordAuthor | piperazinyalkylisoxazole | - |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.